Form 4 for NPCE NeuroPace Inc
Accepted 2026-05-19 16:51:39 ET · period of report 2026-05-15 · accession 0001562229-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-19 16:51 | 2026-05-15 | NPCE | Williams Patrick F. | CFO | A - Grant | $0.00 | +16.8K | 68.7K | +32% | $0 |
| D | 2026-05-19 16:51 | 2026-05-15 | NPCE | Williams Patrick F. | CFO | A - Grant | $0.00 | +44.8K | 44.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | A | A | 16,820 | $0.00 | 68,670 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-15 | A | A | 44,800 | $0.00 | 44,800 | D | $15.36 · — to 2036-05-14 | 44,800 Common Stock | (F2) 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |